Table 1.
Average OCT4 and NANOG expressions (H-Score) in ccRCC, chRCC and pRCC tissues.
| ccRCC | ChRCC | pRCC | P valuea | P valueb | P valuec | P valued | |||
|---|---|---|---|---|---|---|---|---|---|
| OCT4 Expression (H- Score) |
Nuclear | Median (Q1, Q3) | 200 (160, 240) |
210 (200, 300) |
200 (180, 240) |
0.169 | — | — | — |
| Cytoplasmic | Median (Q1, Q3) | 200 (200, 300) |
300 (300, 300) |
300 (300, 300) |
<0.001 | <0.001 | <0.001 | 0.568 | |
| NANOG Expression (H- Score) |
Nuclear | Median (Q1, Q3) | 100 (30, 200) |
200 (100, 200) |
200 (100, 300) |
<0.001 | 0.001 | 0.004 | 0.899 |
| Cytoplasmic | Median (Q1, Q3) | 200 (140, 300) |
300 (300, 300) |
300 (200, 300) |
<0.001 | <0.001 | 0.001 | 0.241 | |
(Q1: the first quartile, Q3: the third quartile).
aComparion between RCC subtypes using Kruskal-Wallis test.
Comparisons between RCC subtypes Mann-Whitney U test based on Bonferroni adjustment:
bComparion between ccRCC and ChRCC subtypes.
cComparion between ccRCC and pRCC subtypes.
dComparion between ChRCC and pRCC subtypes.
Values in bold are statistically significant.
ccRCC indicates clear cell Renal Cell Carcinoma; ChRCC, chromophob Renal Cell Carcinoma; pRCC, papillary Renal Cell Carcinoma.